SPDR S&P Biotech ETF
$124.671.47 %$XBI
About SPDR S&P Biotech ETF (XBI)
SPDR S&P Biotech ETF (XBI) is an exchange-traded fund established on January 31, 2006 and traded on the NYSE exchange. The fund manages approximately $8.30 billion in net assets, making it a significant ETF in its category.
With an expense ratio of 0.35%, SPDR S&P Biotech ETF is considered a low-cost investment option for investors seeking exposure to this asset class.
What You Need to Know About XBI
- Inception Date: January 31, 2006 - providing 20 years of track record
- Assets Under Management: $8.30 billion in net assets
- Expense Ratio: 0.35% annually
- Exchange: NYSE
- Type: Traditional ETF
Compare XBI with other investment options: ETF Screener | Stock Screener
Price History
▼-0.63%
Fund Details
Dividend Yield-0.16%
Inception Date2006-01-31
Net Assets$8.3B
Net Expense Ratio0.00%